City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Jeffrey Weitzel, MD  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 08237 ClinicalTrials.gov Number: NCT01230346

Principal Investigator: Jeffrey Weitzel, MD
Sponsor: NCI Approved External Peer Review

Title:  Intervention to Promote Uptake of Cancer Risk Counseling for Underserved Latinas

COH Protocol Number: 07211 ClinicalTrials.gov Number: NCT01149083

Principal Investigator: Jeffrey Weitzel, MD
Sponsor: NCI Approved External Peer Review

Title:  PHII-96 NCI#8264: Phase II Trial of Single Agent ABT-888 with Post-Progression Therapy of ABT-888 in Combination with Carboplatin in Patients with Stage IV BRCA-Associated Breast Cancer

COH Protocol Number: 96144

Principal Investigator: Jeffrey Weitzel, MD
Sponsor: NCI Approved External Peer Review

Title:  Molecular Genetic Studies in Cancer Patients and Their Relatives

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.